Powder: -20°C for 3 years | In solvent: -80°C for 1 year
SKLB 610 是一种新型多靶点抑制剂,在生化激酶测定中,浓度为 10 μM 时,对血管生成相关酪氨酸激酶 VEGFR2、FGFR2 和 PDGFR 的抑制率分别为 97%、65% 和 55%。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 259 | 现货 | ||
5 mg | ¥ 590 | 现货 | ||
10 mg | ¥ 968 | 现货 | ||
25 mg | ¥ 1,630 | 现货 | ||
50 mg | ¥ 2,420 | 现货 | ||
100 mg | ¥ 3,580 | 现货 | ||
200 mg | ¥ 4,970 | 现货 | ||
500 mg | ¥ 7,750 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 769 | 现货 |
产品描述 | SKLB610, a novel multi-targeted inhibitor, inhibits angiogenesis-related tyrosine kinase VEGFR2, FGFR2, and PDGFR at a rate of 97%, 65%, and 55%, respectively, at the concentration of 10 μM in biochemical kinase assays. |
激酶实验 | PI3K assay: PI3K assay is preformed on whole-cell lysates from CLL or normal B cells. A PI3K ELISA assay is performed. Briefly, whole-cell extracts are added to a mixture of PI(4,5)P2 substrate and reaction buffer containing adenosine triphosphate (ATP) and allowed to incubate at room temperature. The reaction is stopped by adding PI(3,4,5)P3 detector mixed with EDTA (ethylenediaminetetraacetic acid) and allowed to incubate at room temperature for 1 hour. After this time, the mixture is transferred from each well to a PI3K ELISA plate and allowed to incubate 1 hour. Plates are washed and then incubated with secondary detector for 30 minutes. Plates are washed again, and 3,3′,5,5′-tetramethylbenzidine solution is added for 5 minutes at which time H2SO4 is added to stop all reactions. Plates are read at 450 nm on a Labsystems 96-well plate reader. |
分子量 | 415.37 |
分子式 | C21H16F3N3O3 |
CAS No. | 1125780-41-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (120.37 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.4075 mL | 12.0375 mL | 24.0749 mL | 60.1873 mL |
5 mM | 0.4815 mL | 2.4075 mL | 4.815 mL | 12.0375 mL | |
10 mM | 0.2407 mL | 1.2037 mL | 2.4075 mL | 6.0187 mL | |
20 mM | 0.1204 mL | 0.6019 mL | 1.2037 mL | 3.0094 mL | |
50 mM | 0.0481 mL | 0.2407 mL | 0.4815 mL | 1.2037 mL | |
100 mM | 0.0241 mL | 0.1204 mL | 0.2407 mL | 0.6019 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
SKLB 610 1125780-41-7 Angiogenesis Tyrosine Kinase/Adaptors VEGFR FGFR PDGFR SKLB610 SKLB-610 Inhibitor inhibitor inhibit